• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马对感染性攻击和用马疱疹病毒-1抗原进行疫苗接种的黏膜体液免疫反应。

The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.

作者信息

Breathnach C C, Yeargan M R, Sheoran A S, Allen G P

机构信息

M. H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington 40546-0099, USA.

出版信息

Equine Vet J. 2001 Nov;33(7):651-7. doi: 10.2746/042516401776249318.

DOI:10.2746/042516401776249318
PMID:11770985
Abstract

Equine herpesvirus-1 (EHV-1) remains a frequent cause of upper respiratory tract infection and abortion in horses worldwide. However, little is known about the local antibody response elicited in the upper airways of horses following exposure to EHV-1. This study analysed the mucosal humoral immune response of weanling foals following experimental infection with virulent EHV-1, or vaccination with either of 2 commercial vaccines. Twenty weanlings were assigned to 5 groups and were inoculated with, or vaccinated against, EHV-1 following different regimens. Finally, all weanlings were simultaneously challenged intranasally with virulent EHV-1 Army 183 (A183). Nasal wash and serum samples were collected at regular intervals until 13 weeks after final challenge. Nasal washes were assayed for EHV-1-specific equine IgGa, IgGb, IgG(T), IgA, IgM and total virus-specific antibody using an indirect, quantitative ELISA. Total serum antibody responses were also monitored, and clinical signs of EHV-disease were recorded for each individual. Virus-specific IgA dominated the mucosal antibody response elicited in weanlings inoculated with A183, being detectable at up to 3.1 microg/mg total IgA 13 weeks after challenge. Neither inactivated EHV-1 administered i.m., nor attenuated EHV-1 administered intranasally induced detectable mucosal antibodies. EHV-1-specific mucosal antibodies impeded EHV-1 plaque formation in vitro. Such virus-neutralising antibody probably contributes to a reduction of shedding of EHV-1 from the respiratory tract of virus-infected horses.

摘要

马疱疹病毒1型(EHV-1)仍然是全球范围内马匹上呼吸道感染和流产的常见病因。然而,对于马匹暴露于EHV-1后在上呼吸道引发的局部抗体反应知之甚少。本研究分析了断奶幼驹在实验性感染强毒EHV-1或接种两种商业疫苗之一后的黏膜体液免疫反应。将20只断奶幼驹分为5组,按照不同方案接种或接种疫苗对抗EHV-1。最后,所有断奶幼驹同时经鼻内接种强毒EHV-1陆军183株(A183)。定期采集鼻洗液和血清样本,直至末次攻毒后13周。使用间接定量ELISA检测鼻洗液中EHV-1特异性马IgGa、IgGb、IgG(T)、IgA、IgM和总病毒特异性抗体。还监测了血清总抗体反应,并记录了每只动物的EHV疾病临床症状。病毒特异性IgA在接种A183的断奶幼驹引发的黏膜抗体反应中占主导地位,在攻毒后13周时,总IgA中可检测到的含量高达3.1μg/mg。肌肉注射的灭活EHV-1和鼻内接种的减毒EHV-1均未诱导可检测到的黏膜抗体。EHV-1特异性黏膜抗体在体外可阻止EHV-1空斑形成。这种病毒中和抗体可能有助于减少病毒感染马匹呼吸道中EHV-1的脱落。

相似文献

1
The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.马对感染性攻击和用马疱疹病毒-1抗原进行疫苗接种的黏膜体液免疫反应。
Equine Vet J. 2001 Nov;33(7):651-7. doi: 10.2746/042516401776249318.
2
Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.比较鼻腔内接种和肌肉内接种改良的马传染性疱疹病毒 1 型活疫苗对马的保护效果。
Vet Microbiol. 2018 Aug;222:18-24. doi: 10.1016/j.vetmic.2018.06.015. Epub 2018 Jun 19.
3
Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.马疱疹病毒(EHV-1)活疫苗株C147:在受到1型和4型马疱疹病毒攻击后对呼吸道疾病的疗效。
Vet Microbiol. 2003 Mar 20;92(1-2):1-17. doi: 10.1016/s0378-1135(02)00358-9.
4
Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.鼻腔 IgG4/7 抗体反应可保护马免受马疱疹病毒 1 型(EHV-1)感染,包括鼻腔病毒脱落和细胞相关病毒血症。
Virology. 2019 May;531:219-232. doi: 10.1016/j.virol.2019.03.014. Epub 2019 Mar 22.
5
An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.马疱疹病毒 1 型(EHV-1)Ab4 开放阅读框 2 缺失突变株可提供针对 EHV-1 感染和疾病的免疫和保护。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01011-19. Print 2019 Nov 15.
6
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).灭活联合疫苗与减毒活病毒疫苗针对神经致病性1型马疱疹病毒(EHV-1)攻毒感染的疗效比较。
Vaccine. 2006 Apr 24;24(17):3636-45. doi: 10.1016/j.vaccine.2006.01.062. Epub 2006 Feb 13.
7
Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.马和驹接种马疱疹病毒 1 型和 4 型(EHV-1 和 EHV-4)疫苗后的血清学反应和临床结果。
Vet Microbiol. 2012 Nov 9;160(1-2):9-16. doi: 10.1016/j.vetmic.2012.04.042. Epub 2012 May 8.
8
Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.马、怀孕母马和幼驹对马疱疹病毒1糖蛋白D的血清抗体反应。
Vet Immunol Immunopathol. 2005 May 1;105(1-2):47-57. doi: 10.1016/j.vetimm.2004.12.012.
9
Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.马流感和马疱疹病毒的联合疫苗接种——一种实用方法。
Influenza Other Respir Viruses. 2016 Sep;10(5):433-7. doi: 10.1111/irv.12396. Epub 2016 Jul 2.
10
Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.用EHV-1糖蛋白D和B接种母马和非常年幼的马驹,可减少EHV-1呼吸道攻击后的病毒脱落。
Vet Immunol Immunopathol. 2006 May 15;111(1-2):97-108. doi: 10.1016/j.vetimm.2006.01.012. Epub 2006 Feb 28.

引用本文的文献

1
Equine herpesvirus type 1 (EHV-1) replication at the upper respiratory entry site is inhibited by neutralizing EHV-1-specific IgG1 and IgG4/7 mucosal antibodies.1型马疱疹病毒(EHV-1)在上呼吸道入口处的复制受到中和性EHV-1特异性IgG1和IgG4/7黏膜抗体的抑制。
J Virol. 2024 Jun 13;98(6):e0025024. doi: 10.1128/jvi.00250-24. Epub 2024 May 14.
2
Viremia and nasal shedding for the diagnosis of equine herpesvirus-1 infection in domesticated horses.病毒血症和鼻分泌物用于诊断家养马的马疱疹病毒-1 感染。
J Vet Intern Med. 2024 May-Jun;38(3):1765-1791. doi: 10.1111/jvim.16958. Epub 2023 Dec 9.
3
Vaccination for the prevention of equine herpesvirus-1 disease in domesticated horses: A systematic review and meta-analysis.
马疱疹病毒 1 病在驯养马中的预防接种:系统评价和荟萃分析。
J Vet Intern Med. 2024 May-Jun;38(3):1858-1871. doi: 10.1111/jvim.16895. Epub 2023 Nov 6.
4
An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.马疱疹病毒 1 型(EHV-1)Ab4 开放阅读框 2 缺失突变株可提供针对 EHV-1 感染和疾病的免疫和保护。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01011-19. Print 2019 Nov 15.
5
Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.神经致病性1型马疱疹病毒Ab4株的ORF2基因缺失可降低毒力,同时保持强大的免疫原性。
BMC Vet Res. 2018 Aug 22;14(1):245. doi: 10.1186/s12917-018-1563-4.
6
Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.马疱疹病毒 4 型 UL56 和 UL49.5 蛋白独立地下调细胞表面主要组织相容性复合体 I 的表达。
J Virol. 2012 Aug;86(15):8059-71. doi: 10.1128/JVI.00891-12. Epub 2012 May 23.
7
Immunological correlates of vaccination and infection for equine herpesvirus 1.马疱疹病毒1型疫苗接种和感染的免疫相关因素
Clin Vaccine Immunol. 2012 Feb;19(2):235-41. doi: 10.1128/CVI.05522-11. Epub 2011 Dec 28.
8
Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.ETIF 缺失对马疱疹病毒 1 型载体疫苗的安全性和免疫原性的影响。
J Virol. 2010 Nov;84(22):11602-13. doi: 10.1128/JVI.00677-10. Epub 2010 Sep 8.
9
IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA.马的 IgA:马多聚免疫球蛋白受体和 J 链的克隆及重组马 IgA 形式的特性。
Mucosal Immunol. 2010 Nov;3(6):610-21. doi: 10.1038/mi.2010.38. Epub 2010 Jul 14.